Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEMO: rhNGF eye drops for Retinitis Pigmentosa
NCT02609165Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2015
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cenegermin in retinitis pigmentosa (RP), cystoid macular edema (CME), sponsored by IRCCS Ospedale San Raffaele. Started May 2015; status: completed.
02
Drugs
cenegermin
03
Conditions
retinitis pigmentosa (RP)cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT02609165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609165.